(Q28740991)

16

0 references

Susanna Schraen-Maschke

4

0 references

Jean-Charles Lambert

1

0 references

Luc Buée

17

0 references

Philippe Amouyel

19

0 references

Claudine Berr

10

0 references

Julie Dumont

Julie Dumont

7

0 references

Simon M. Laws

Simon Laws

6

0 references

Cassandra Szoeke

Cassandra Szoeke

14

0 references

Christophe Tzourio

Christophe Tzourio

15

0 references

Jean Dallongeville

2

Jean Dallongeville

0 references

Kathryn A Ellis

Kathryn A Ellis

3

0 references

Ralph Martins

Ralph Martins

18

0 references

Colin L. Masters

12

Colin L Masters

0 references

Florence Richard

8

Florence Richard

0 references

Dominique Cottel

9

Dominique Cottel

0 references

author name string

James Lui

5

0 references

David Ames

11

0 references

Christopher C Rowe

Creative Commons Attribution 4.0 International

13

0 references

language of work or name

English

0 references

publication date

15 April 2011

0 references

published in

PLOS One

0 references

volume

6

0 references

issue

4

0 references

page(s)

e18536

0 references

copyright license

start time

15 April 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078119

Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078119

Apolipoprotein A-I directly interacts with amyloid precursor protein and inhibits A beta aggregation and toxicity

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078119

Amyloid (beta)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078119

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078119

Neurovascular regulation in the normal brain and in Alzheimer's disease

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078119

Effects of Blood Pressure Changes on Alzheimer’s Disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078119

Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078119

Vascular Smooth Muscle Cell Signaling Mechanisms for Contraction to Angiotensin II and Endothelin-1.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078119

Hypertension in the elderly and the very old.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078119

The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078119

High serum Abeta and vascular risk factors in first-degree relatives of Alzheimer's disease patients

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078119

The age-dependent relation of blood pressure to cognitive function and dementia

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078119

Alzheimer's amyloid-beta as a preventive antioxidant for brain lipoproteins

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3078119

Clearance of amyloid beta-peptide from brain: transport or metabolism?

3 June 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018536

beta-Amyloid-mediated vasoactivity and vascular endothelial damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018536

Lysosomal deposition of Abeta in cultures of brain vascular smooth muscle cells is enhanced by iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018536

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018536

Non-invasive characterization of beta-amyloid(1-40) vasoactivity by functional magnetic resonance imaging in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018536

Vascular Factors and Risk of Dementia: Design of the Three-City Study and Baseline Characteristics of the Study Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018536

Trends in plasma lipids, lipoproteins and dyslipidaemias in French adults, 1996-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018536

Role of peroxynitrite in the vasoactive and cytotoxic effects of Alzheimer's beta-amyloid1-40 peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018536

Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018536

Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018536

Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018536

Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018536

Association of plasma amyloid with risk of dementia: The prospective Three-City Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018536

Secretion of Alzheimer's disease Abeta amyloid peptide by activated human platelets

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21525986

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Hypertension and dementia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21525986

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Characteristics of the in vitro vasoactivity of beta-amyloid peptides

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21525986

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PONE.0018536

1 reference

ADS bibcode

2011PLoSO...618536L

0 references

1 reference

1 reference

PubMed publication ID

21525986

1 reference